TY - JOUR AU - Compston, A. AU - Coles, A. PY - 2002 DA - 2002// TI - Multiple sclerosis JO - Lancet VL - 359 UR - https://doi.org/10.1016/S0140-6736(02)08220-X DO - 10.1016/S0140-6736(02)08220-X ID - Compston2002 ER - TY - JOUR AU - Lesaux, J. AU - Jadback, G. AU - Harraghy, C. E. PY - 1999 DA - 1999// TI - Improving the convenience of home-based interferon beta-1a therapy for multiple sclerosis JO - J Neurosci Nurs VL - 31 UR - https://doi.org/10.1097/01376517-199906000-00006 DO - 10.1097/01376517-199906000-00006 ID - Lesaux1999 ER - TY - JOUR AU - Tremlett, H. L. AU - Oger, J. PY - 2003 DA - 2003// TI - Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS JO - Neurology VL - 61 UR - https://doi.org/10.1212/01.WNL.0000078885.05053.7D DO - 10.1212/01.WNL.0000078885.05053.7D ID - Tremlett2003 ER - TY - JOUR AU - Costello, K. AU - Kennedy, P. AU - Scanzillo, J. PY - 2008 DA - 2008// TI - Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term JO - Medscape J Med VL - 10 ID - Costello2008 ER - TY - JOUR AU - Treadaway, K. AU - Cutter, G. AU - Salter, A. AU - Lynch, S. AU - Simsarian, J. AU - Corboy, J. AU - Jeffery, D. AU - Cohen, B. AU - Mankowski, K. AU - Guarnaccia, J. AU - Schaeffer, L. AU - Kanter, R. AU - Brandes, D. AU - Kaufman, C. AU - Duncan, D. AU - Marder, E. AU - Allen, A. AU - Harney, J. AU - Cooper, J. AU - Woo, D. AU - Stüve, O. AU - Racke, M. AU - Frohman, E. M. PY - 2009 DA - 2009// TI - Factors that influence adherence with disease-modifying therapy in MS JO - J Neurol VL - 256 UR - https://doi.org/10.1007/s00415-009-0096-y DO - 10.1007/s00415-009-0096-y ID - Treadaway2009 ER - TY - JOUR AU - Al-Sabbagh, A. AU - Bennet, R. AU - Kozma, C. AU - Dickson, M. AU - Meletiche, D. PY - 2008 DA - 2008// TI - Medication gaps in disease-modifying therapy for multiple sclerosis are associated with an increased risk of relapse: findings from a national managed care database JO - J Neurol VL - 255 ID - Al-Sabbagh2008 ER - TY - JOUR AU - Steinberg, S. C. AU - Faris, R. J. AU - Chang, C. F. AU - Chan, A. AU - Tankersley, M. A. PY - 2010 DA - 2010// TI - Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study JO - Clin Drug Investig VL - 30 UR - https://doi.org/10.2165/11533330-000000000-00000 DO - 10.2165/11533330-000000000-00000 ID - Steinberg2010 ER - TY - JOUR AU - Singer, B. AU - Lucas, S. AU - Kresa-Reahl, K. AU - Perrin Ross, A. AU - Blake, P. PY - 2008 DA - 2008// TI - Optimizing adherence to multiple sclerosis therapies JO - Int J MS Care VL - 10 UR - https://doi.org/10.7224/1537-2073-10.4.113 DO - 10.7224/1537-2073-10.4.113 ID - Singer2008 ER - TY - JOUR AU - Cox, D. AU - Stone, J. PY - 2006 DA - 2006// TI - Managing self-injection difficulties in patients with relapsing-remitting multiple sclerosis JO - J Neurosci Nurs VL - 38 UR - https://doi.org/10.1097/01376517-200606000-00005 DO - 10.1097/01376517-200606000-00005 ID - Cox2006 ER - TY - JOUR AU - Mohr, D. C. AU - Boudewyn, A. C. AU - Likosky, W. AU - Levine, E. AU - Goodkin, D. E. PY - 2001 DA - 2001// TI - Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject JO - Ann Behav Med VL - 23 UR - https://doi.org/10.1207/S15324796ABM2302_7 DO - 10.1207/S15324796ABM2302_7 ID - Mohr2001 ER - TY - JOUR AU - Lugaresi, A. PY - 2009 DA - 2009// TI - Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? JO - Expert Opin Drug Deliv VL - 6 UR - https://doi.org/10.1517/17425240903134769 DO - 10.1517/17425240903134769 ID - Lugaresi2009 ER - TY - JOUR AU - Amato, M. P. AU - Zipoli, V. AU - Portaccio, E. PY - 2006 DA - 2006// TI - Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies JO - J Neurol Sci VL - 245 UR - https://doi.org/10.1016/j.jns.2005.08.019 DO - 10.1016/j.jns.2005.08.019 ID - Amato2006 ER - TY - JOUR AU - Cramer, J. A. AU - Cuffel, B. J. AU - Divan, V. AU - Al-Sabbagh, A. AU - Glassman, M. PY - 2006 DA - 2006// TI - Patient satisfaction with an injection device for multiple sclerosis treatment JO - Acta Neurol Scand VL - 113 UR - https://doi.org/10.1111/j.1600-0404.2005.00568.x DO - 10.1111/j.1600-0404.2005.00568.x ID - Cramer2006 ER - TY - JOUR AU - Devonshire, V. AU - Arbizu, T. AU - Borre, B. AU - Lang, M. AU - Lugaresi, A. AU - Singer, B. AU - Verdun di Cantogno, E. AU - Cornelisse, P. PY - 2010 DA - 2010// TI - Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study JO - BMC Neurol VL - 10 UR - https://doi.org/10.1186/1471-2377-10-28 DO - 10.1186/1471-2377-10-28 ID - Devonshire2010 ER - TY - JOUR AU - Lugaresi, A. AU - Durastanti, V. AU - Gasperini, C. AU - Lai, M. AU - Pozzilli, C. AU - Orefice, G. AU - Sotgiu, S. AU - Pucci, E. AU - Ardito, B. AU - Millefiorini, E. PY - 2008 DA - 2008// TI - Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study JO - Clin Neuropharmacol VL - 31 UR - https://doi.org/10.1097/wnf.0b013e3181571a8e DO - 10.1097/wnf.0b013e3181571a8e ID - Lugaresi2008 ER - TY - JOUR AU - Mikol, D. AU - Lopez-Bresnahan, M. AU - Taraskiewicz, S. AU - Chang, P. AU - Rangnow, J. PY - 2005 DA - 2005// TI - A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis JO - Mult Scler VL - 11 UR - https://doi.org/10.1191/1352458505ms1197oa DO - 10.1191/1352458505ms1197oa ID - Mikol2005 ER - TY - JOUR AU - Pozzilli, C. AU - Schweikert, B. AU - Ecari, U. AU - Oentrich, W. PY - 2011 DA - 2011// TI - Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis-Results of the BetaPlus observational cohort study JO - J Neurol Sci VL - 307 UR - https://doi.org/10.1016/j.jns.2011.04.026 DO - 10.1016/j.jns.2011.04.026 ID - Pozzilli2011 ER - TY - JOUR AU - Polman, C. H. AU - Reingold, S. C. AU - Edan, G. AU - Filippi, M. AU - Hartung, H. P. AU - Kappos, L. AU - Lublin, F. D. AU - Metz, L. M. AU - McFarland, H. F. AU - O'Connor, P. W. AU - Sandberg-Wollheim, M. AU - Thompson, A. J. AU - Weinshenker, B. G. AU - Wolinsky, J. S. PY - 2005 DA - 2005// TI - Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria' JO - Ann Neurol VL - 58 UR - https://doi.org/10.1002/ana.20703 DO - 10.1002/ana.20703 ID - Polman2005 ER - TY - JOUR AU - Andrade, S. E. AU - Kahler, K. H. AU - Frech, F. AU - Chan, K. A. PY - 2006 DA - 2006// TI - Methods for evaluation of medication adherence and persistence using automated databases JO - Pharmacoepidemiol Drug Saf VL - 15 UR - https://doi.org/10.1002/pds.1230 DO - 10.1002/pds.1230 ID - Andrade2006 ER - TY - JOUR AU - Sikka, R. AU - Xia, F. AU - Aubert, R. E. PY - 2005 DA - 2005// TI - Estimating medication persistency using administrative claims data JO - Am J Manag Care VL - 11 ID - Sikka2005 ER - TY - JOUR AU - Halpern, R. AU - Agarwal, S. AU - Dembek, C. AU - Borton, L. AU - Lopez-Bresnahan, M. PY - 2011 DA - 2011// TI - Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis JO - Patient Prefer Adherence VL - 5 UR - https://doi.org/10.2147/PPA.S15702 DO - 10.2147/PPA.S15702 ID - Halpern2011 ER - TY - JOUR AU - Reynolds, M. W. AU - Stephen, R. AU - Seaman, C. AU - Rajagopalan, K. PY - 2010 DA - 2010// TI - Persistence and adherence to disease modifying drugs among patients with multiple sclerosis JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007990903554257 DO - 10.1185/03007990903554257 ID - Reynolds2010 ER - TY - JOUR AU - Kappos, L. AU - Traboulsee, A. AU - Constantinescu, C. AU - Eralinna, J. P. AU - Forrestal, F. AU - Jongen, P. AU - Pollard, J. AU - Sandberg-Wollheim, M. AU - Sindic, C. AU - Stubinski, B. AU - Uitdehaag, B. AU - Li, D. PY - 2006 DA - 2006// TI - Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS JO - Neurology VL - 67 UR - https://doi.org/10.1212/01.wnl.0000237994.95410.ce DO - 10.1212/01.wnl.0000237994.95410.ce ID - Kappos2006 ER - TY - JOUR PY - 1998 DA - 1998// TI - Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)03334-0 DO - 10.1016/S0140-6736(98)03334-0 ID - ref24 ER - TY - JOUR PY - 2001 DA - 2001// TI - PRISMS-4: long-term efficacy of interferon-beta-1a in relapsing MS JO - Neurology VL - 56 UR - https://doi.org/10.1212/WNL.56.12.1628 DO - 10.1212/WNL.56.12.1628 ID - ref25 ER - TY - JOUR AU - Bruce, J. M. AU - Hancock, L. M. AU - Lynch, S. G. PY - 2010 DA - 2010// TI - Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report JO - Mult Scler VL - 16 UR - https://doi.org/10.1177/1352458509351897 DO - 10.1177/1352458509351897 ID - Bruce2010 ER - TY - JOUR AU - Rio, J. AU - Porcel, J. AU - Tellez, N. AU - Sanchez-Betancourt, A. AU - Tintore, M. AU - Arevalo, M. J. AU - Nos, C. AU - Montalban, X. PY - 2005 DA - 2005// TI - Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis JO - Mult Scler VL - 11 UR - https://doi.org/10.1191/1352458505ms1173oa DO - 10.1191/1352458505ms1173oa ID - Rio2005 ER - TY - JOUR AU - Singer, B. AU - Wray, S. AU - Miller, T. AU - Cascione, M. AU - Gupta, A. AU - Pardo, G. AU - Watsky, E. AU - Mercer, B. AU - Dangond, F. PY - 2011 DA - 2011// TI - Final results from a 12-week, phase IIIb trial to evaluate an electronic autoinjector in patients with relapsing multiple sclerosis JO - Neurology VL - 76 ID - Singer2011 ER - TY - JOUR AU - Johnson, K. P. AU - Brooks, B. R. AU - Cohen, J. A. AU - Ford, C. C. AU - Goldstein, J. AU - Lisak, R. P. AU - Myers, L. W. AU - Panitch, H. S. AU - Rose, J. W. AU - Schiffer, R. B. PY - 1995 DA - 1995// TI - Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial JO - Neurology VL - 45 UR - https://doi.org/10.1212/WNL.45.7.1268 DO - 10.1212/WNL.45.7.1268 ID - Johnson1995 ER - TY - JOUR AU - Schwid, S. R. AU - Thorpe, J. AU - Sharief, M. AU - Sandberg-Wollheim, M. AU - Rammohan, K. AU - Wendt, J. AU - Panitch, H. AU - Goodin, D. AU - Li, D. AU - Chang, P. AU - Francis, G. PY - 2005 DA - 2005// TI - Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE study JO - Arch Neurol VL - 62 UR - https://doi.org/10.1001/archneur.62.5.785 DO - 10.1001/archneur.62.5.785 ID - Schwid2005 ER - TY - JOUR AU - Panitch, H. AU - Goodin, D. AU - Francis, G. AU - Chang, P. AU - Coyle, P. AU - O'Connor, P. AU - Li, D. AU - Weinshenker, B. PY - 2005 DA - 2005// TI - Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial JO - J Neurol Sci VL - 239 UR - https://doi.org/10.1016/j.jns.2005.08.003 DO - 10.1016/j.jns.2005.08.003 ID - Panitch2005 ER - TY - JOUR AU - Reess, J. AU - Haas, J. AU - Gabriel, K. AU - Fuhlrott, A. AU - Fiola, M. PY - 2002 DA - 2002// TI - Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-1a (AVONEX) therapy JO - Mult Scler VL - 8 ID - Reess2002 ER - TY - JOUR AU - Ng, J. L. AU - Morgan, D. J. AU - Loh, N. K. AU - Gan, S. K. AU - Coleman, P. L. AU - Ong, G. S. AU - Prentice, D. PY - 2011 DA - 2011// TI - Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis JO - Med J Aust VL - 194 ID - Ng2011 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/12/7/prepub UR - http://www.biomedcentral.com/1471-2377/12/7/prepub ID - ref34 ER -